loadpatents
name:-0.0063331127166748
name:-0.036338090896606
name:-0.00051379203796387
Durette; Philippe L. Patent Filings

Durette; Philippe L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Durette; Philippe L..The latest application filed is for "nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection".

Company Profile
0.32.4
  • Durette; Philippe L. - New Providence NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Nucleoside cyclic phosphoramidates for the treatment of RNA-dependent RNA viral infection
Grant 8,148,349 - Meppen , et al. April 3, 2
2012-04-03
Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection
Grant 8,071,568 - Narjes , et al. December 6, 2
2011-12-06
Nucleoside Aryl Phosphoramidates For The Treatment Of Rna-dependent Rna Viral Infection
App 20100035835 - Narjes; Frank ;   et al.
2010-02-11
Nucleoside Cyclic Phosphoramidates For The Treatment Of Rna-dependent Rna Viral Infection
App 20100022468 - Meppen; Malte ;   et al.
2010-01-28
Fluorinated Pyrrolo[2,3-D]Pyrimidine Nucleosides for the Treatment of Rna-Dependent Rna Viral Infection
App 20080280842 - MacCoss; Malcolm ;   et al.
2008-11-13
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
App 20070004669 - Carroll; Steven S. ;   et al.
2007-01-04
Heterocyclic amide compounds as cell adhesion inhibitors
Grant 6,903,075 - Durette , et al. June 7, 2
2005-06-07
Substituted .beta.-alanine derivatives as cell adhesion inhibitors
Grant 6,645,939 - Durette , et al. November 11, 2
2003-11-11
Biarylalkanoic acids as cell adhesion inhibitors
Grant 6,291,511 - Durette , et al. September 18, 2
2001-09-18
Sulfonamides as cell adhesion inhibitors
Grant 6,221,888 - Durette , et al. April 24, 2
2001-04-24
16-pyrazinyl-substituted-4-aza-androstane 5-.alpha.-reductase isozyme 1 inhibitors
Grant 5,910,497 - Durette , et al. June 8, 1
1999-06-08
Cycloalkyl tachykinin receptor antagonists
Grant 5,750,549 - Caldwell , et al. May 12, 1
1998-05-12
Substituted 4-aza-5.alpha.-androstan-ones as 5.alpha.-reductase inhibitors
Grant 5,693,809 - Durette , et al. December 2, 1
1997-12-02
Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
Grant 5,679,700 - Caldwell , et al. October 21, 1
1997-10-21
Cyclic amidine analogs as inhibitors of nitric oxide synthase
Grant 5,629,322 - Guthikonda , et al. May 13, 1
1997-05-13
Substituted azetidinones as anti-inflammatory and antidegenerative agents
Grant 5,591,737 - Doherty , et al. January 7, 1
1997-01-07
15-substituted 4-azasteroids
Grant 5,359,071 - Durette , et al. October 25, 1
1994-10-25
6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
Grant 5,236,899 - Durette * August 17, 1
1993-08-17
Immunosuppressive fluorinated cyclosporin analogs
Grant 5,227,467 - Durette , et al. July 13, 1
1993-07-13
Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
Grant 5,100,880 - Durette , et al. March 31, 1
1992-03-31
N-alkenyl-3-hydroxybenzo[b]thiophene-2-carboxamide derivatives as dual cyclooxygenase and lipoxygenase inhibitors
Grant 5,068,248 - Tischler , et al. November 26, 1
1991-11-26
Derivatives of 3-hydroxyazabenzo(beta)thiophene useful as 5-lipoxygenase inhibitors
Grant 5,006,532 - Baker , et al. April 9, 1
1991-04-09
Steroidal glycolipids as host resistance stimulators against viral infection
Grant 4,970,199 - Durette , et al. November 13, 1
1990-11-13
Steroidal glycolipids as host resistance stimulators against viral infection
Grant 4,942,154 - Durette , et al. * July 17, 1
1990-07-17
Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
Grant 4,914,188 - Dumont , et al. April 3, 1
1990-04-03
Derivatives of 3-hydroxyazabenzo[b]thiophene useful as 5-lipoxygenase inhibitors
Grant 4,904,672 - Baker , et al. February 27, 1
1990-02-27
Dipeptidyl 4-0-,6-0-acyl-2-amino-2-deoxy-D-glucose compositions and methods of use in AIDS-immunocompromised human hosts
Grant 4,868,155 - Durette , et al. September 19, 1
1989-09-19
Dipeptidyl 2-amino-1,2-dideoxy-D-glucose derivatives as host resistance enhancers in AIDS-immunocompromised hosts and methods of use
Grant 4,868,157 - Durette September 19, 1
1989-09-19
Dipeptidyl saccharides as host resistance enhancers in AIDS-immuno-compromised hosts and methods of use
Grant 4,866,035 - Durette September 12, 1
1989-09-12
Dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose compositions and methods of use in aids-immunocompromised human hosts
Grant 4,866,036 - Durette September 12, 1
1989-09-12
5-methylthio-3-hydroxybenzo [b]thiophene-2-carboxamide derivatives as cyclooxygenase and lipoxygenase inhibitors
Grant 4,800,211 - Tischler , et al. January 24, 1
1989-01-24
Steroidal glycolipids as host resistance stimulators
Grant 4,652,553 - Hagmann , et al. March 24, 1
1987-03-24
Immunologically active dipeptidyl saccharides and methods of preparation
Grant 4,377,570 - Durette , et al. March 22, 1
1983-03-22
Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
Grant 4,368,190 - Shen , et al. January 11, 1
1983-01-11
Immunologically active dipeptidyl 2-amino-1,2-dideoxy-D-glucose derivatives and methods of preparation
Grant 4,315,913 - Durette February 16, 1
1982-02-16
1-Substituted glycopyranosides
Grant 4,228,274 - Ponpipom , et al. October 14, 1
1980-10-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed